KU Leuven
Leuven, Belgium
NCT Number: NCT04043546
The study is an observational feasibility study to evaluate the feasibility of a combined aerobic+resistance training program in patients with IC.
Looking for future studies?
Notify Me50 year–90 year
All sexes
Interventional
Not applicable
Leuven, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Personalized exercise program based on the inclusion testing and patient screening will be provided to the patient. The program will consist of a gradual walking program as well as a gradual resistance training program using therabands.
Time frame: 4 weeks
self-developed questionnaire based evaluation of user satisfaction
Time frame: 4 weeks
pain free and maximal walking distance are recorded using the Gardner treadmill protocol.
Time frame: 2 months
Physical activity, defined total active energy expenditure (kcal) is obtained from objective measurement of physical activity during 7 consecutive days using the Sensewear device.
KU Leuven
Other
Observational Feasability Study of Home-based Training With Therabands in PAD-patients - Addressing the Uncertainty of Acceptance, Satisfaction and Usability of a Home-based, Tele-monitored Program Combining Aerobic and Resistance Components in PAD-patients.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04853719
Arterial Occlusive Diseases, Arteriosclerosis
Santo André, São Paulo, Brazil
View Trial DetailsNCT05059899
Arterial Occlusive Diseases, Arteriosclerosis
Coventry, West Midlands, United Kingdom
View Trial DetailsNCT03547817
Arterial Occlusive Diseases, Arteriosclerosis
Oslo, Norway
View Trial DetailsNCT01131013
Arterial Occlusive Diseases, Arteriosclerosis
Phoenix, Arizona, United States
View Trial Details